Operating Expenses Summary of SciVision Biotech Inc.

SciVision Biotech Inc.'s latest annual operating expenses in 2023 was 312.85 Million TWD , up 31.86% from previous year.
SciVision Biotech Inc.'s latest quarterly operating expenses in 2024 Q2 was 85.12 Million TWD , down -18.49% from previous quarter.
SciVision Biotech Inc. reported a annual operating expenses of 237.25 Million TWD in annual operating expenses 2022, up 7.9% from previous year.
SciVision Biotech Inc. reported a annual operating expenses of 219.89 Million TWD in annual operating expenses 2021, up 11.83% from previous year.
SciVision Biotech Inc. reported a quarterly operating expenses of 85.12 Million TWD for 2024 Q2, down -18.49% from previous quarter.
SciVision Biotech Inc. reported a quarterly operating expenses of 39 Million TWD for 2023 Q1, down -44.79% from previous quarter.

Annual Operating Expenses Chart of SciVision Biotech Inc. (2023 - 2009)

Historical Annual Operating Expenses of SciVision Biotech Inc. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	312.85 Million TWD	31.86%
2022	237.25 Million TWD	7.9%
2021	219.89 Million TWD	11.83%
2020	196.64 Million TWD	14.81%
2019	171.27 Million TWD	25.69%
2018	136.26 Million TWD	11.98%
2017	121.68 Million TWD	22.49%
2016	99.34 Million TWD	-13.94%
2015	115.43 Million TWD	0.51%
2014	114.83 Million TWD	33.7%
2013	85.89 Million TWD	19.02%
2012	72.16 Million TWD	31.25%
2011	54.98 Million TWD	8.27%
2010	50.78 Million TWD	5.25%
2009	48.24 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	104.43 Million TWD	10.74%
2024 Q2	85.12 Million TWD	-18.49%
2023 Q1	39 Million TWD	-44.79%
2023 FY	312.85 Million TWD	31.86%
2023 Q4	94.3 Million TWD	5.26%
2023 Q3	89.59 Million TWD	-0.4%
2023 Q2	89.96 Million TWD	130.64%
2022 FY	237.25 Million TWD	7.9%
2022 Q4	70.65 Million TWD	14.68%
2022 Q3	61.6 Million TWD	0.26%
2022 Q2	61.44 Million TWD	41.1%
2022 Q1	43.55 Million TWD	-32.25%
2021 FY	219.89 Million TWD	11.83%
2021 Q1	48.56 Million TWD	-13.04%
2021 Q2	52.19 Million TWD	7.47%
2021 Q3	54.84 Million TWD	5.08%
2021 Q4	64.28 Million TWD	17.2%
2020 FY	196.64 Million TWD	14.81%
2020 Q1	38.77 Million TWD	-25.51%
2020 Q2	49.32 Million TWD	27.21%
2020 Q3	52.68 Million TWD	6.82%
2020 Q4	55.85 Million TWD	6.01%
2019 Q2	36.82 Million TWD	-6.33%
2019 FY	171.27 Million TWD	25.69%
2019 Q4	52.05 Million TWD	20.86%
2019 Q3	43.07 Million TWD	16.95%
2019 Q1	39.31 Million TWD	3.96%
2018 Q2	31.57 Million TWD	-7.83%
2018 FY	136.26 Million TWD	11.98%
2018 Q3	32.61 Million TWD	3.3%
2018 Q4	37.81 Million TWD	15.96%
2018 Q1	34.25 Million TWD	3.29%
2017 Q3	28.22 Million TWD	-21.51%
2017 FY	121.68 Million TWD	22.49%
2017 Q2	35.96 Million TWD	47.83%
2017 Q1	24.32 Million TWD	-12.89%
2017 Q4	33.16 Million TWD	17.49%
2016 Q2	23.39 Million TWD	2.66%
2016 Q3	25.22 Million TWD	7.81%
2016 Q4	27.92 Million TWD	10.71%
2016 FY	99.34 Million TWD	-13.94%
2016 Q1	22.79 Million TWD	-28.6%
2015 Q2	28.37 Million TWD	25.67%
2015 Q4	31.92 Million TWD	-1.96%
2015 FY	115.43 Million TWD	0.51%
2015 Q1	22.57 Million TWD	-46.92%
2015 Q3	32.55 Million TWD	14.75%
2014 Q2	24.28 Million TWD	6.85%
2014 FY	114.83 Million TWD	33.7%
2014 Q4	42.53 Million TWD	68.17%
2014 Q3	25.29 Million TWD	4.16%
2014 Q1	22.72 Million TWD	-12.45%
2013 Q2	19.22 Million TWD	-0.59%
2013 Q4	25.95 Million TWD	21.41%
2013 FY	85.89 Million TWD	19.02%
2013 Q1	19.33 Million TWD	-12.79%
2013 Q3	21.38 Million TWD	11.24%
2012 Q4	22.17 Million TWD	15.55%
2012 Q3	19.18 Million TWD	17.05%
2012 Q1	14.4 Million TWD	4.06%
2012 Q2	16.39 Million TWD	13.78%
2012 FY	72.16 Million TWD	31.25%
2011 Q3	14.65 Million TWD	0.0%
2011 FY	54.98 Million TWD	8.27%
2011 Q4	13.84 Million TWD	-5.49%
2011 Q2	- TWD	0.0%
2010 FY	50.78 Million TWD	5.25%
2010 Q4	- TWD	0.0%
2009 FY	48.24 Million TWD	0.0%

Peer Operating Expenses Comparison of SciVision Biotech Inc.

Name	Operating Expenses	Operating Expenses Difference
Nang Kuang Pharmaceutical Co., Ltd.	495.65 Million TWD	36.88%
Maxigen Biotech Inc.	274.24 Million TWD	-14.079%
Bionime Corporation	673.63 Million TWD	53.557%
Pegavision Corporation	1.68 Billion TWD	81.457%
Visco Vision Inc.	522.44 Million TWD	40.117%

Global Stocks Search

SciVision Biotech Inc. (1786.TW)

Operating Expenses Summary of SciVision Biotech Inc.

Annual Operating Expenses Chart of SciVision Biotech Inc. (2023 - 2009)

Historical Annual Operating Expenses of SciVision Biotech Inc. (2023 - 2009)

Peer Operating Expenses Comparison of SciVision Biotech Inc.